senseonics Profile Banner
Senseonics Inc Profile
Senseonics Inc

@senseonics

Followers
3K
Following
13
Media
15
Statuses
19

Senseonics, the makers of Eversense, is focused on the design, development and commercialization of long-term CGM to advance patient care.

Germantown, MD
Joined May 2019
Don't wanna be here? Send us removal request.
@senseonics
Senseonics Inc
7 years
Senseonics Safety Information https://t.co/kw5cP4JMGm
14
1
21
@senseonics
Senseonics Inc
6 years
Senseonics Announces a Positive Coverage Decision for Eversense CGM From Humana https://t.co/VZvVyKcsLN
10
11
42
@senseonics
Senseonics Inc
6 years
Senseonics Announces a Positive Coverage Decision for Eversense CGM from Health Care Service Corporation - Blue Cross Blue Shield of Illinois, Montana, New Mexico, Oklahoma and Texas https://t.co/UlP7eIpiWZ
0
5
22
@senseonics
Senseonics Inc
6 years
Senseonics Announces the Completion of US Patient Enrollment in the PROMISE 180-Day Sensor Clinical Study https://t.co/0qdTfGo6vU
1
8
21
@senseonics
Senseonics Inc
6 years
Are you living with diabetes, or know someone who is? Do you have a desire to help others learn more about the day-to-day life with diabetes? Be sure to check out our community page. https://t.co/VSSwDBM7Mk
0
5
13
@senseonics
Senseonics Inc
6 years
Are you living with diabetes, or know someone who is? Do you have a desire to help others learn more about the day-to-day life with diabetes? Be sure to check out our community page. https://t.co/VSSwDBM7Mk
1
0
5
@senseonics
Senseonics Inc
6 years
Senseonics Announces Two Positive Blue Cross Blue Shield Coverage Decisions for Eversense CGM https://t.co/s2hrBivfC2
0
4
16
@senseonics
Senseonics Inc
6 years
Real-World Experience of Repeat Users Shows Long-Term Safety of the Implantable Eversense CGM System in the Home-Use Setting https://t.co/wrkWHDRpxG
2
0
5
@senseonics
Senseonics Inc
6 years
Senseonics Publishes Eversense® CGM Real-World Data from First U.S. Users https://t.co/dfQ3gU6zJQ
0
3
9
@senseonics
Senseonics Inc
6 years
Join us August 28th & 29th for one of two Facebook LIVE events with our Eversense Unstoppable Ambassadors: news anchor Darrell Greene @t1d_g, powerlifter Chris Ruden @chrisruden and author Laura Kronen @beyouonlybetter Register here: https://t.co/O3gCISSGHG
1
2
5
@senseonics
Senseonics Inc
6 years
Join us August 28th & 29th for one of two Facebook LIVE events with our Eversense Unstoppable Ambassadors: news anchor Darrell Greene @t1d_g, powerlifter Chris Ruden @chrisruden and author Laura Kronen @beyouonlybetter Register here: https://t.co/O3gCISSGHG
1
2
5
@senseonics
Senseonics Inc
6 years
All About the Eversense XL Continuous Glucose Monitor (CGM) https://t.co/r1qBHkee5u
0
1
6
@T1DLylic
T1DLylic
6 years
Endo upon reviewing 2 months of data since @EversenseCGM: insertion "This is the flatest glucose graph I've ever seen. This is unbelievable. Keep doing what you're doing because this is amazing." #LCHP #IntermittentFasting #Type1Diabetes #MultipleDailyInjections
1
7
41
@senseonics
Senseonics Inc
6 years
If you are attending AADE in Houston next week be sure to visit us in Booth #1300. #AADE2019 https://t.co/836Jmssq4L
1
0
3
@senseonics
Senseonics Inc
6 years
Geo-Med and The Veterans Affairs Medical Center in Omaha, Nebraska is the first VA in the country to offer EversenseCGM. Now, veterans with diabetes in Omaha (and across the country) can experience the freedom of using an up to 3-month CGM system. #CGM ... https://t.co/KweBoVYLCK
1
0
5
@EversenseCGM
EversenseCGM
6 years
Eversense is proud to support @BeyondType1's @typeonerun initiative. If you have type 1 diabetes and you like running or would like to start running, join in! To get started, visit https://t.co/BHNJzjfcsS
2
1
5
@senseonics
Senseonics Inc
6 years
If you missed the talk on User Acceptance of the Eversense® CGM System in a Home Use Setting: The House Study by Dr. Magnus Londahl at ADA 2019, you can read the abstract here: https://t.co/9juibRgl0t
0
0
5
@senseonics
Senseonics Inc
6 years
If you missed the poster sessions at ADA, click the link below to view the abstract: Post Market Clinical Follow-Up (PMCF) Registry to Demonstrate the Long Term Safety of the Eversense CGM System, that was presented at 2019 ADA. https://t.co/Jsuo6HVq6n
0
0
4
@senseonics
Senseonics Inc
6 years
Senseonics Announces FDA Approval for a Non-Adjunctive Indication (Dosing Claim) for the Eversense® 90-day CGM System https://t.co/Jk0J9HmBir #Senseonics #EversenseCGM
1
0
9